Page last updated: 2024-11-02

pilsicainide and Cardiac Failure

pilsicainide has been researched along with Cardiac Failure in 2 studies

pilsicainide: structure given in first source
pilsicainide : A secondary carboxamide resulting from the formal condensation of the amino group of 2,6-dimethylaniline with the carboxy group of (tetrahydro-1H-pyrrolizin-7a(5H)-yl)acetic acid. It is a sodium channel blocker which is used as an antiarrhythmic drug for the management of atrial tachyarrhythmias in Japan.

Research Excerpts

ExcerptRelevanceReference
"Pilsicainide (75 mg/day) was administered to reduce the LVOTO."1.56Development of Pulmonary Edema Despite Negative Fluid Balance with Diuretics in a Patient with Heart Failure and Sigmoid Septum. ( Kamono, M; Komatsu, R; Miyazaki, K; Onuma, Y, 2020)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Miyazaki, K1
Onuma, Y1
Komatsu, R1
Kamono, M1
Nattel, S1

Other Studies

2 other studies available for pilsicainide and Cardiac Failure

ArticleYear
Development of Pulmonary Edema Despite Negative Fluid Balance with Diuretics in a Patient with Heart Failure and Sigmoid Septum.
    The Tokai journal of experimental and clinical medicine, 2020, Apr-20, Volume: 45, Issue:1

    Topics: Aged, 80 and over; Diuretics; Furosemide; Heart Failure; Humans; Lidocaine; Male; Pulmonary Edema; V

2020
Effects of ionic remodeling on cardiac antiarrhythmic drug actions.
    Journal of cardiovascular pharmacology, 2001, Volume: 38, Issue:6

    Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Down-Regulation; Electric C

2001